News | April 17, 2013

MDCT Better Determines Transcatheter Aortic Valve Implant Size

Study looks at patients who underwent an MDCT scan and transthoracic and transesophageal echocardiography before having a TAVI

April 17, 2013 — Multi-detector computed tomography (MDCT) is a better way to measure annular size in patients with aortic stenosis who are candidates for transcatheter aortic valve implantation (TAVI) than two dimensional echocardiography according to a new study.

The study included 69 patients who underwent an MDCT scan as well as transthoracic and transesophageal echocardiography before having a TAVI. TAVI is done to treat patients with severe aortic stenosis who are not surgical candidates. Aortic stenosis is a common disorder in the elderly.

"Measurement of the aortic annulus is crucial for implant size selection and procedure success," said Vineeta Sethi, M.D., lead author of the study. "If the implanted valve is too small, blood will leak outside of the valve apparatus back into the heart."

Measurements obtained on MDCT were significantly different than those obtained on echocardiography.

"The decision to use a certain valve size would have been changed in about 55 percent of patients in our study if MDCT measurements had been used rather than echocardiography measurements," she said. "This includes patients who were wrongly sized as well as those who would have been disqualified from having TAVI due to the large size of their aortic annulus.”

She also stated that transesophagea/transthoracic echocardiographically derived measurements of the aortic annulus are the current standard for measurement but with the increasing awareness of the discrepancies in measurement between MDCT and echocardiography, more people are using MDCT derived measurements to choose appropriate valve size.

For more information: www.arrs.org

 


Related Content

News | Cardiovascular Clinical Studies

Nov. 10, 2025 —Genomics, a science-led techbio company, has today announced new research that suggests polygenic risk ...

Home November 12, 2025
Home
News | Cardiovascular Clinical Studies

Oct. 21, 2025 – AskBio Inc., a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG ...

Home October 21, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 25, 2025 — Merck, known as MSD outside of the United States and Canada, has announced that new clinical trial and ...

Home August 25, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 18, 2025 — (Newswise) It’s often mistaken for a heart attack, but Takotsubo cardiomyopathy — previously known as ...

Home August 21, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 20, 2025 — A major international study published in Atherosclerosis* has found that routinely testing for ...

Home August 20, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 4, 2025 — Marea Therapeutics, Inc., a clinical-stage biotechnology company that develops next-generation medicines ...

Home August 04, 2025
Home
News | Cardiovascular Clinical Studies

July 16, 2025 — Medtronic has announced that the first patient has been enrolled in the PEripheral Onyx Liquid Embolic ...

Home July 22, 2025
Home
News | Cardiovascular Clinical Studies

June 11, 2025 — Bayer and the Broad Institute have have extended their research collaboration of 10 years by an ...

Home June 11, 2025
Home
News | Cardiovascular Clinical Studies

May 27, 2025 — Despite scientific advances in cardiovascular care, people in living in rural areas and other communities ...

Home May 27, 2025
Home
News | Cardiovascular Clinical Studies

May 20, 2025 — Shockwave Medical, Inc., part of Johnson & Johnson MedTechhas announced the 30-day primary endpoint ...

Home May 21, 2025
Home
Subscribe Now